Injective’s INJ heads toward Wall Street with proposed INJC staking ETF

Canary Capital's amended filing for a staked INJ fund joins at least three pending applications as Injective's CEO argues a 2027 timeline is too cautious Injective ’s native token, INJ, may soon have a ticker that looks right at home in a standard brokerage account: INJC . Canary Capital is behind the proposed Staked INJ ETF. It submitted an amended registration statement to the SEC on September 24, 2026. The product would offer INJ exposure without a crypto wallet, and it plans to stake most of its holdings for extra yield.